Pharmint

Glossary

A B C D E F G H I L M N P Q R S T U

CAS (Chemical Abstracts Service)

What is CAS Number? CAS stands for Chemical Abstracts Service, a division of the American Chemical Society. It operates the CAS Registry, which assigns a unique identifier (CAS Registry Number, or CAS RN) to every chemical substance disclosed in scientific literature. These identifiers are used globally to unambiguously identify molecules, compounds, polymers, biological sequences, and other materials. Why is CAS […]

CAS (Chemical Abstracts Service) Read More »

CDMO (Contract Development & Manufacturing Organization)

What Is a CDMO? A CDMO (Contract Development & Manufacturing Organization) is a third-party service provider offering comprehensive R&D and manufacturing capabilities. From early drug development, formulation, analytical testing, clinical supply, to commercial-scale manufacturing, CDMOs serve as end-to-end partners for pharmaceutical and biotech firms. Why Are CDMOs Important in Pharma? CDMOs accelerate development timelines while reducing capital expenditure. They bring expert

CDMO (Contract Development & Manufacturing Organization) Read More »

CEP (Certificate of Suitability)

What Is a CEP (Certificate of Suitability)? A CEP (Certificate of Suitability) is an official document issued by the EDQM that certifies an active pharmaceutical ingredient (API) or excipient conforms to the quality standards outlined in the European Pharmacopoeia (Ph. Eur.). It replaces the need to submit detailed substance data in each EU Marketing Authorization

CEP (Certificate of Suitability) Read More »

Certificate of Analysis (COA)

What Is a Certificate of Analysis (COA)? A Certificate of Analysis (COA) is an official, batch-specific document issued by a manufacturer or quality control lab that verifies a product’s identity, strength, purity, and conformance to predefined specifications. It’s essential for quality assurance and regulatory compliance across APIs, excipients, drugs, and reference materials. Why Is a COA Important in the Pharma

Certificate of Analysis (COA) Read More »

Certificate of Origin (COO)

What is a Certificate of Origin(COO)? A Certificate of Origin (COO) is an official trade document that certifies the country where a product was manufactured, processed, or produced. In the pharmaceutical and chemical export industry, it serves as proof that goods originate from a particular country — a key requirement for customs authorities, trade agreements, and import licensing procedures. The document is

Certificate of Origin (COO) Read More »

Certificate of Pharmaceutical Product (CPP)

What is a Certificate of Pharmaceutical Product (CPP)? A Certificate of Pharmaceutical Product (CPP) is an official document issued by a regulatory authority under the World Health Organization (WHO) Certification Scheme. It confirms that a specific pharmaceutical product is authorized for sale in the country of origin and complies with WHO Good Manufacturing Practice (GMP) standards. The CPP is one of the most recognized

Certificate of Pharmaceutical Product (CPP) Read More »

Clinical Trial Supply

What is Clinical Trial Supply in Pharma? Clinical Trial Supply refers to the set of investigational products and ancillary materials (drugs, placebos, comparators, devices, etc.), along with their packaging, labeling, storage, and logistics, required to support a clinical trial from site initiation through close‑out. It ensures that every trial site and participant has the right product, at

Clinical Trial Supply Read More »

Commercial Invoice

What is a Commercial Invoice? A Commercial Invoice is a legal export document issued by the seller to the buyer, detailing the nature, quantity, value, and terms of sale for goods in international trade. In the pharmaceutical industry, it is a critical document used for customs clearance, pricing validation, and regulatory compliance, particularly in transactions involving APIs, excipients, or controlled substances. Why

Commercial Invoice Read More »

Contract Manufacturing Organization (CMO)

What is a Contract Manufacturing Organization (CMO)? A Contract Manufacturing Organization (CMO) is a third-party company that provides drug manufacturing services under contract to pharmaceutical firms. CMOs may produce APIs, intermediates, or finished dosage forms, and must operate in compliance with current Good Manufacturing Practices (cGMPs). According to the FDA, CMOs must be registered establishments, inspected regularly, and subject to the same regulatory

Contract Manufacturing Organization (CMO) Read More »

Controlled Substance

What Is a Controlled Substance? A controlled substance is a drug, chemical, or precursor regulated by law due to potential for abuse, addiction, or public health threat. These are classified into schedules based on medical utility, abuse risk, and safety, reflecting stringent national and international control frameworks. Why Is Regulation of Controlled Substances Crucial? Strict governance ensures:

Controlled Substance Read More »

Controlled Substances Act (CSA)

What is Controlled Substances Act (CSA)? CSA, short for the Controlled Substances Act, is a cornerstone U.S. federal statute—enacted in 1970 and signed into law by President Richard Nixon—that regulates the manufacturing, importation, distribution, and use of certain drugs and chemicals. It establishes five drug schedules based on accepted medical use, abuse potential, and dependence liability. Why Does the Controlled Substances Act (CSA)

Controlled Substances Act (CSA) Read More »

CRO (Contract Research Organization)

What is a CRO in Pharmaceutical and Biotech Research? A CRO (Contract Research Organization) is a specialized company contracted by pharmaceutical, biotechnology, or medical device sponsors to perform trial-related duties—from early-stage research to clinical trial management and post-marketing support. According to ICH, while sponsors delegate these tasks, ultimate responsibility for trial quality and integrity remains with them. Why are CROs Important

CRO (Contract Research Organization) Read More »

Current Good Manufacturing Practice (cGMP)

What is cGMP in Pharmaceutical Manufacturing? cGMP, or current Good Manufacturing Practice, refers to regulations enforced by the U.S. FDA to ensure drug products are consistently produced and controlled to meet quality standards. These regulations are codified in 21 CFR Part 210 (manufacturing, processing, packing, holding of drugs) and Part 211 (finished pharmaceuticals). These rules establish the methods, facilities, and controls essential for

Current Good Manufacturing Practice (cGMP) Read More »

Custom Synthesis

What is Custom Synthesis? Custom synthesis is the bespoke creation of specific chemical compounds—like APIs, intermediates, reference standards, or fine chemicals—tailored to a client’s exact requirements in terms of structure, purity, quantity, and documentation. It’s typically performed under confidentiality agreements. Why is Custom Synthesis Vital in Pharma? Custom synthesis supports drug discovery and development by enabling rapid

Custom Synthesis Read More »

Scroll to Top